韩国Panagene
帕纳锦社为全球学术和政府研究机构以及制药和生物科技公司提供产品和服务，以支持他们所从事的 PNA 研究工作。PNA 技术用于生命科学研究、诊断学以及治疗学。帕纳锦社自身从事的研究和开发工作，同时着重于 PNA 聚合体的化学合成与制造以及 PNA 阵列 (PNA array) 和诊断学方面的创新突破。帕纳锦社成立于2001年，总部设在韩国大田，公司业务遍布全球。
 PNA 是脱氧核糖核酸 (DNA) 的仿制品，该产品的独有特性令其在许多应用中独具优势。帕纳锦社估计目前的 PNA 市场约为脱氧核糖核酸 (DNA)/核糖核酸 (RNA) 合成市场的5%，但获得此许可后，帕纳锦社相信 PNA 市场将出现显著增长。

Panagene provides products and services that support academic, government research institutions, pharmaceutical and biotech companies worldwide in their PNA research efforts. The PNA technology is used in life science research, diagnostics and in therapeutics. Panagene's own research and development efforts are focused on breakthrough innovation not only in chemical synthesis and manufacturing of PNA oligomers, but also in PNA array and diagnostics. Founded in 2001, Panagene is headquartered in Daejeon, South Korea, and conducts business around the world. The company globally employs approximately 20 professionals in South Korea and in the US.